Abstract
The results of clinical and Epstein-Barr virus (EBV) serological studies on nine Chediak-Higashi syndrome (CHS) patients are reported. Persistently elevated antibodies to the viral capsid antigen (VCA) and the restricted component of the early antigen complex (EA-R) developed in six patients who experienced primary EBV infection which either remained silent or were accompanied by clinical signs of infectious mononucleosis (IM). Hepatosplenomegaly and moderate lymphadenopathy, both clinical signs of the accelerated phase, remained detectable in the six patients for a long period of time after seroconversion. The clinical, serological, and histopathological observations are suggestive of a nonmalignant lymphoproliferative disease and consistent with an immunodeficiency to EBV. The abnormal serological responses to EBV in CHS are therefore considered manifestations of a chronic active EBV infection which may result in lethal lymphoproliferation. The three as yet seronegative CHS patients revealed no signs of the accelerated lymphoproliferative phase of the syndrome.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Beguez-Cesar A: Neutropenia crónica maligna familiar con granulaciones atípicas de los leucocitos. Bol Soc Cuban Pediat 15:900–922, 1943
Blume RS, Wolff SM: The Chediak-Higashi syndrome: Studies in four patients and a review of the literature. Medicine 51:247–280, 1972
Merino F, Klein GO, Henle W, Ramírez-Duque P, Forsgren M, Amesty C: Low NK activity and elevated anti EBV antibodies in Chediak-Higashi patients. Clin Immunol Immunopathol 27:326–339, 1983
Merino F: Immunodeficiency to Epstein-Barr virus in Chediak-Higashi syndrome.In Immune Deficiency and Cancer: Epstein-Barr Virus and Lymphoproliferative Malignancies, DT Purtilo (ed). New York, Plenum Press, 1984, pp 143–165
Merino F: Síndrome de Chediak-Higashi: Un modelo de immunodeficiencia, síndrome linfoproliferativo y virus de Epstein-Barr. Immunología (Spain) 3:29–36, 1984
Merino F, Rodríguez F, Biondo M: Altered lectin-mediated cytotoxicity in Chediak-Higashi patients. Clin Immunol Immunopathol 33:139–143, 1984
Henle W, Henle G: Epstein-Barr virus and human malignancies.In Advances in Viral Oncology, G Klein (ed). New York, Raven Press, 1985, Vol 6, pp 201–238
Henle W, Henle G: Seroepidemiology of the virus.In The Epstein-Barr Virus, MA Epstein, BG Achong (eds). Berlin, Springer-Verlag, 1979, pp 61–78
Miller G, Niederman JC, Andrews LL: Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis. N Engl J Med 288:229–232, 1973
Sixby JW, Nedrod JG, Raab-Traub N, Hanes RA, Pagano JS: Epstein-Barr replication in oropharyngeal epithelial cells. N Engl J Med 310:1225–1230, 1984
Yao QY, Rickinson AB, Epstein MA: A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals. Int J Cancer 35:35–42, 1985
Chang RS, Lewis JP, Abildgaard CF: Prevalence of oropharyngeal excreters of leukocyte-transforming agents among a human population. N Engl J Med 289:1325–1329, 1973
Purtilo DT (ed): Immune Deficiency and Cancer: Epstein-Barr Virus and Lymphoproliferative Malignancies. New York, Plenum Press, 1984
Klein G, Purtilo DT: Epstein-Barr virus and lymphoproliferative diseases in immunodeficient individuals. Cancer Res 41:4209–4304, 1981
Dubois RE, Seeley JK, Brus I, Sakamoto K, Ballow M, Harada S, Bechtold TA, Pearson G, Purtilo DT: Chronic mononucleosis syndrome. South Med J 77:1376–1382, 1984
Jones JF, Ray G, Minnich LL, Hicks MJ, Kibler R, Lucas DO: Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: Elevated anti-early antigen antibodies. Ann Intern Med 102:1–7, 1985
Straus SE, Tosato G, Armstrong G, Lawley T, Preble OT, Henle W, Pearson G, Epstein J, Brus I, Blaese RM: Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med 102:7–16, 1985
Ramírez-Duque P, Arends T, Merino F: Chediak-Higashi Syndrome: Description of a cluster in a Venezuelan Andean isolated region. J Med 13:431–451, 1982
Leal I, Soto H, Merino F, Goihman-Yahr M, DeSalvo L, Amesty C: Chediak-Higashi syndrome in a Venezuelan black child. J Am Acad Dermatol 13:337–342, 1985
Henle W, Henle G, Horowitz CA: Epstein-Barr virus-specific diagnostic tests in infectious mononucleosis. Hum Pathol 5:551–565, 1974
Reedman BM, Klein G: Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and nonproducer lymphoblastoid cell lines. Int J Cancer 11:499–520, 1973
Henle W, Henle G: Antibodies to the R component of Epstein-Barr virus-induced early antigens in Burkitt's lymphoma exceeding in titer antibodies to Epstein-Barr viral capsid antigen. J Natl Cancer Inst 58:785–786, 1977
Rickinson AB, Moss DJ, Wallace LE, Rowe M, Misko IS, Epstein MA, Pope JH: Long ter T-cell mediated immunity to Epstein-Bart virus. Cancer Res 41:4216–4221, 1981
Klein E, Ernberg I, Masucci MG, Szigeti R, Wu YT, Masucci G, Svedmyr E: T-cell response to B-cells and Epstein-Barr virus antigens in infectious mononucleosis. Cancer Res 41:4210–4215, 1981
Svedmyr E, Ernberg I, Seeley J, Weiland O, Masucci G, Tsukuda K, Szigeti R, Masucci MG, Blombren H, Berthold W, Henle W, Klein G: Virologic, immunologic and clinical observations on a patient during the incubation, acute and convalescent phases of infectious mononucleosis. Clin Immunol Immunopathol 30:437–450, 1984
Henle W, Henle G: Epstein-Barr virus-specific serology in immunologically compromised individuals. Cancer Res 41:4222–4225, 1981
Merino F, Pauza M, Purtilo DT: Anti Epstein-Barr virus memory T-cell response in Chediak-Higashi syndrome patients. Immunol Lett 12:51–54, 1986
Dent PB, Fish LA, White JG, Good RA: Chediak-Higashi syndrome. Observations on the nature of the associated malignancy. Lab Invest 15:1634–1637, 1966
Efrati P, Jonas W: Chediak's anomaly of leukocytes in malignant lymphoma associated with leukemic manifestations: Case report with necropsy. Blood 13:1063–1067, 1958
Padgett GA, Reiquam CW, Gorham JR, Henson JB, O'Mary CC: Comparative studies of the Chediak-Higashi syndrome. Pathology. Am J Pathol 51:553–571, 1967
Risdall RJ, McKenna RW, Nesbit ME, Drivit W, Belfour HH, Simmons RL, Brunning RD: Virus-associated hemophagocytic syndrome. A benign histiocytic proliferation distinct from malignant histiocytosis. Cancer 44:994–1002, 1979
Targan SR, Oseas R: The “lazy” cells of Chediak-Higashi syndrome. J Immunol 130:2671–2674, 1983
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Merino, F., Henle, W. & Ramírez-Duque, P. Chronic active Epstein-Barr virus infection in patients with Chediak-Higashi syndrome. J Clin Immunol 6, 299–305 (1986). https://doi.org/10.1007/BF00917330
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00917330